prof. MUDr. Mgr. Marek Mráz, Ph.D.
Research Group Leader Senior, Marek Mráz Research Group
Office: bldg. E35/216
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8143 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 263
2021
-
GAB1 reguluje tonickou AKT signalizaci a migraci buněk chronické lymfatické leukémie: implikace pro kombinační léčbu s BCR inhibitory.
Year: 2021, type: Conference abstract
-
Ibrutinib Blocks CD40 Signalling in CLL in Vivo by Reducing TRAF4 Levels.
Year: 2021, type: Conference abstract
-
Ibrutinib blocks CD40 signalling in malignant B cells by reducing TRAF4 levels.
Year: 2021, type: Conference abstract
-
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3K delta inhibitor idelalisib
haematologica, year: 2021, volume: 106, edition: 11, DOI
-
IL4-STAT6 Signaling Induces CD20 in Chronic Lymphocytic Leukemia and This Axis Is Repressed by PI3Kδ Inhibitor Idelalisib.
Year: 2021, type: Conference abstract
-
LncRNAs in adaptive immunity: role in physiological and pathological conditions
RNA Biology, year: 2021, volume: 18, edition: 5, DOI
-
Microenvironmental interactions in B cell leukemias and lymphomas: Implications for targeted therapy.
Year: 2021, type: Conference abstract
-
MicroRNAs in the regulation of microenvironmental interactions of malignant B cells.
Year: 2021, type: Conference abstract
-
miR-29 influences CD40 signaling in chronic lymphocytic leukemia (CLL): and axis affected by BCR inhibitors.
Year: 2021, type: Conference abstract
-
miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR inhibitors
Blood, year: 2021, volume: 137, edition: 18, DOI